Heron Therapeutics | Dochód Netto





Dochód Netto Zmiana Data
ALKERMES USD 49.34M 33.42M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amarin USD -7.74M 6.4M 2025-09
ANI Pharmaceuticals USD 32.35M 6.08M 2025-12
Anika Therapeutics USD -4.87M 16.99M 2025-03
Arrowhead Research USD 30.81M 54.56M 2025-12
Eisai JPY 17.18B 7.02B 2025-12
Emergent BioSolutions USD -261.3M 78.3M 2023-06
Esperion Therapeutics USD -29.52M 32.4M 2024-09
GlaxoSmithKline GBP 636M 1.38B 2025-12
Heron Therapeutics USD -4.85M 4.39M 2024-09
Insmed USD -328.48M 41.54M 2025-12
Ligand Pharmaceuticals USD 117.27M 112.43M 2025-09
Merck USD 2.96B 2.82B 2025-12
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Omeros USD -32.23M 23.81M 2024-09
Pacira USD 1.64M 3.8M 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Surmodics USD -11.54M 3.99M 2024-09
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
Veracyte USD 41.15M 22.01M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12


Heron Therapeutics Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2026.